Evidence map›Paper›PMID 40481913›Full record

ArticleIntensive care medicine experimental2025

Prediction of lung overdistension during mechanical ventilation using micro-RNA and gene expression.

Cecilia López-Martínez, Paula Martín-Vicente, Laura Amado-Rodríguez, Inés López-Alonso, Margarita Fernández-Rodríguez, Adrián González-López, Pablo Martínez-Camblor, Juan Gómez, Andrew J Boyle, Cecilia M O'Kane and 4 more

Abstract read
In one paragraph

Article in Intensive care medicine experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Update on acute respiratory failure.Intensive care medicine · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Cecilia López-Martínez *Centro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Paula Martín-Vicente *Centro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Laura Amado-RodríguezCentro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Inés López-AlonsoCentro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Margarita Fernández-RodríguezInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Adrián González-LópezCentro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Pablo Martínez-CamblorDepartment of Biomedical Data Sciences, Geisel School of Medicine, Dartmouth College, Hanover, USA.
Juan GómezCentro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.
Andrew J BoyleWellcome-Wolfson Institute for Experimental Medicine, School of Medicine Dentistry and Biomedical Science, Queen's University, Belfast, UK.
Cecilia M O'KaneWellcome-Wolfson Institute for Experimental Medicine, School of Medicine Dentistry and Biomedical Science, Queen's University, Belfast, UK.
Daniel F McAuleyWellcome-Wolfson Institute for Experimental Medicine, School of Medicine Dentistry and Biomedical Science, Queen's University, Belfast, UK.
James N TsoporisKeenan Research Centre for Biomedical Science, St Michael's Hospital, University of Toronto, 30 Bond Street, Room 4-008, Toronto, ON, M5B 1WB, Canada.
Claudia Dos Santos *Keenan Research Centre for Biomedical Science, St Michael's Hospital, University of Toronto, 30 Bond Street, Room 4-008, Toronto, ON, M5B 1WB, Canada. Claudia.DosSantos@unityhealth.to.
Guillermo M Albaiceta *Centro de Investigación Biomédica en Red (CIBER)-Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. gma@crit-lab.org.ORCID http://orcid.org/0000-0002-9276-3253

Funding

Centro de Investigación Biomedica en Red-Enfermedades respiratorias CB17/06/00021Gobierno del Principado de Asturias AYUD/2021/52014Gobierno del Principado de Asturias AYUD/2022/33523Gobierno del Principado de Asturias IDE/2024/000797Instituto de Salud Carlos III FI21/00168Instituto de Salud Carlos III JR22/00066Ministerio de Ciencia e Innovación PRX19/00175Ministerio de Universidades FPU18/02965
6 · The paper itself

Abstract

backgroundOverstretching of lung parenchyma may lead to injury, especially during mechanical ventilation. To date, there are no specific biomarkers of lung stretch, but transcriptomic signatures have not been explored. Our objective was to identify stretch-specific signatures using micro-RNA and gene expression.

methodsData on micro-RNA and RNA expression in response to stretch in experimental models were systematically pooled. Signatures were identified as those micro-RNAs or genes with differential expression in samples from stretched cells or tissues, and optimized using a greedy algorithm. Expression data was used to calculate transcriptomic scores. The accuracy of these scores was validated in animal models of lung injury, ex vivo mechanically ventilated human lungs, and bronchoalveolar lavage fluid (BALF, n = 7) and in serum samples (n = 31) of mechanically ventilated patients.

resultsSix micro-RNAs (mir-383, mir-877, mir-130b; mir-146b, mir-181b, and mir-26b) were differentially expressed in stretched cell cultures (n = 24). Amongst the genes regulated by these micro-RNAs, a 451-gene signature was identified in vitro (n = 106) and refined using data from animal models (n = 143) to obtain a 6-gene signature (Lims1, Atp6v1c1, Dedd, Bclb7, Ppp1r2 and F3). Transcriptomic scores were significantly higher in samples submitted to stretch or injurious mechanical ventilation. The microRNA and RNA signatures were validated in human tissue, BALF and serum, with areas under the ROC curve between 0.7 and 1 to identify lung overdistention.

conclusionsLung cell stretch induces the expression of specific micro-RNA and genes. The potential of these signatures to identify lung stretch in a clinical setting must be explored.

Indexed as

Lung stretchMicro-RNAsOverdistensionTranscriptomics

Identifiers

PMID40481913
PMCPMC12145361

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.